[1]张绍武,李治国,宁洁,等.子宫内膜癌患者血清人附睾分泌蛋白4水平及其临床意义[J].医学临床研究,2014,31(2):394-395. [2]Galgano MT,Hampton GM,Friemon HF JR.Comprehensive analysis of HE4 expression in normal and malignant human tissues[J].Mod Pathol,2006,19(6):847-853. [3]杨晓霞,柏明,刘丽敏,等.慢性肾脏病患者血清人附睾蛋白4与疾病进展的关系[J].肾脏病与透析肾移植杂志,2016,25(2):128-133. [4]Chen KS,Lai MK,Huang CC,et al.Agrologic cancers in uremic patient-s[J].Am J Kidney Dis,1995,25:694. [5]Barouchos N,Papazafiropulou A,Iacovidou N,et al.Comp-arison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease(COPD) exacerbations[J].Scand J Clin Lab Invest,2015,75(2):126-132. [6]吴萍,叶伟民,李晨,等.人附睾蛋白4对慢性肾脏疾病的诊断价值研究[J].检验医学,2015,30(5):461-464. [7]LeBleu VS,Teng Y,O Connell JT,et al.Identification of human epididymis pr-otein-4 as a fibroblast-derived mediator of fibrosis[J].Nat Med,2013,19(2):227-231. [8]Escudero JM,Auge JM,Filella X,et al.Comparison of serum human e-pididymis protein 4 with cancer antigen 125 as a tumor marker in patients wi-th malignant and nonmalignant diseases[J].Clin Chem,2011,57(11):1534-1544. [9]张晓光,汪年松,高云朝,等.血液透析患者血清肿瘤标志物的检测及临床意义[J].中国中西医结合肾病杂志,2010,11(4):318-321. [10]谭菲,胡志欢.血液透析患者血清肿瘤标志物的检测及意义[J].中国医院药学杂志,2016,36(8):245. [11]李波.维持性血液透析患者血清肿瘤标志物的检测及意义[J].中国肿瘤临床与康复,2013,20(3):201-203.
2017, Vol. 34 
